8519 A phase 2, randomized trial (CONCERT-1) of chemoradiotherapy with or without panitumumab in patients (pts) with unresected, locally advanced squamous cell carcinoma of the head and neck (SCCHN): Interim pooled safety analysis

A.Fortin; A.Cmelak; R.Mesía; H.Minn; A.T.C.Chan; A.C.Yunes; M.C.Merlano; S.Singh; M.Smitt; M.Henke

首页> 外文期刊>European Journal of Cancer Supplements >8519 A phase 2, randomized trial (CONCERT-1) of chemoradiotherapy with or without panitumumab in patients (pts) with unresected, locally advanced squamous cell carcinoma of the head and neck (SCCHN): Interim pooled safety analysis

【24h】

8519 A phase 2, randomized trial (CONCERT-1) of chemoradiotherapy with or without panitumumab in patients (pts) with unresected, locally advanced squamous cell carcinoma of the head and neck (SCCHN): Interim pooled safety analysis

机译：8519在未切除，局部晚期头颈部鳞状细胞癌（SCCHN）的患者（pts）中接受或不接受panitumumab的放化疗的2期随机试验（CONCERT-1）：中期合并安全性分析

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2009年第2期|共1页
作者
A.Fortin; A.Cmelak; R.Mesía; H.Minn; A.T.C.Chan; A.C.Yunes; M.C.Merlano; S.Singh; M.Smitt; M.Henke;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. 8516 A phase 2 randomized trial of radiotherapy (RT) plus panitumumab compared to chemoradiotherapy in patients with unresected, locally advanced squamous cell carcinoma of the head and neck (SCCHN): interim pooled safety analysis [J] . J.Giralt, J.M.Trigo, S.Nuyts, European Journal of Cancer Supplements . 2009,第2期

机译：8516在未切除的局部晚期头颈部鳞状细胞癌（SCCHN）患者中进行放疗（RT）加帕尼单抗与化学放疗比较的2期随机试验：中期合并安全性分析
2. Chemoradiotherapy with or without panitumumab in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-1): a randomised, controlled, open-label phase 2 trial [J] . Mesia Ricard, Henke Michael, Fortin Andre, The lancet oncology . 2015,第2期

机译：未切除，局部晚期头颈部鳞状细胞癌患者的化学放疗联合或不联合帕尼单抗（CONCERT-1）：一项随机，对照，开放标签的2期试验
3. 8514 SPECTRUM, a phase III trial for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN) receiving chemotherapy with or without panitumumab: interim pooled safety analysis [J] . J.St?hlmacher, I.Davidenko, E.Winquist, European Journal of Cancer Supplements . 2009,第2期

机译：8514 SPECTRUM，一项接受或不接受帕尼单抗化疗的复发性和/或转移性头颈部鳞状细胞癌（SCCHN）患者的III期试验：中期合并安全性分析
4. CCND1 as a Predictive Biomarker of Neoadjuvant Chemotherapy in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma [C] . Zhien Feng, Lizhen Wang, Bingshun Wang, Academic Committee Conference of Shanghai key lab of stomatology . 2011

机译：CCND1作为局部晚期头颈部鳞状细胞癌患者新辅助化疗的预测生物标志物
5. Inflammatory mechanisms of chemokine receptor 7 expression in metastatic squamous cell carcinoma of the head and neck (SCCHN). [D] . Mburu, Yvonne K. 2011

机译：趋化因子受体7在头颈部转移性鳞状细胞癌（SCCHN）中表达的炎症机制。
6. Phase I trial of concurrent chemoradiotherapy with docetaxel cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN) [O] . H Katori, M Tsukuda, I Mochimatu, 2004

机译：多西他赛顺铂和5-氟尿嘧啶（TPF）同步放化疗的I期临床试验用于局部晚期头颈部鳞状细胞癌（SCCHN）
7. Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial [O] . Giralt Jordi, Trigo Jose, Nuyts Sandra, 2015

机译：帕尼单抗联合放疗与放化疗联合治疗未切除的局部晚期头颈部鳞状细胞癌（CONCERT-2）：一项随机，对照，开放标签的2期试验

8519 A phase 2, randomized trial (CONCERT-1) of chemoradiotherapy with or without panitumumab in patients (pts) with unresected, locally advanced squamous cell carcinoma of the head and neck (SCCHN): Interim pooled safety analysis

著录项

相似文献

相关主题

期刊订阅